USPTO 2015–2025 USPTO PatentsView US Corporation

Suturegard Medical Inc.

USPTO PatentsView assignee record - 9 granted patents across 2 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Suturegard ranks #30,299 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 2 technology areas.

#30,299
of 49,997 US assignees by volume
14th percentile
by Innovation Score (24.3/100)
12.2
avg claims per patent
+200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R30299 · US Corporation #30,299 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 9 grants
  • MID-PACK #30,299/49,997
  • PHOTO-FINISH Sunshine Guojian…
  • CPC-NARROW A61B · 2 areas
  • INNOV-THIN 24.3/100
  • CLAIMS-RICH 12.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +200% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sunshine Guojian Pharmaceutical (SHANGHAI) Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Suturegard

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Suturegard's Innovation Score is 24.3/100 (14th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Suturegard's grants concentrate

Suturegard Medical Inc. is a focused PatentsView assignee: 2 CPC subclasses with 77.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (3 grants) versus a trough of 2 in 2019. By volume, Suturegard sits between Sunshine Guojian Pharmaceutical (SHANGHAI) Co., Ltd. and Synbio Tech Inc..

Suturegard's three-year grant acceleration

Suturegard Medical Inc. shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Suturegard's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Suturegard holds 9 patents at rank #30,115, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Suturegard

By rank, the assignees closest to #30,115 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Suturegard's primary technology class.

Suturegard's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 14th percentile higher than 14% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2019202020232025 1
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Suturegard Medical Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 2 22.2%
2020 3 33.3%
2023 3 33.3%
2025partial year 1 11.1%

Where it ranks

Overall rank by patents

#30,299

of 49,997 tracked assignees

Innovation Score

24.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Suturegard Medical Inc.'s patent record in context - here's where to go next.

  • Suturegard Medical Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 77.8% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #30,299 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Suturegard Medical Inc. against Sunshine Guojian Pharmaceutical (SHANGHAI) Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 24.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.